Adiponectin serum level is an independent and incremental predictor of all-cause mortality after transcatheter aortic valve replacement.

ABSTRACT:

Background

Quantifiable biomarkers may be useful for a better risk and frailty assessment of patients referred for transcatheter aortic valve implantation (TAVI).

Hypothesis

To determine if adiponectin serum concentration predicts all-cause mortality in patients undergoing TAVI.

Methods

77 consecutive patients, undergoing TAVI, were analyzed. The CT axial slices at the level of the fourth lumbar vertebra were used to measure the psoas muscle area, and its low-density muscle fraction (LDM (%)). To assess the operative risk, the STS (Society of Thoracic Surgeons Predicted Risk of Mortality) score, Log. Euroscore, and Euroscore II were determined. A clinical frailty assessment was performed. ELISA kits were used to measure adiponectin serum levels. We searched for a corr

SUBMITTER: Walpot J 

PROVIDER: S-EPMC9574742 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature